/Investor DB

Arsenal — 2017 Investments

5 investments dated 2017 · listed companies and verified rows first · show all

Aptimmune Biologicsaptimmune.com𝕏Jun 2017✓ verifiedAcquired

Aptimmune develops vaccines for swine health, partnering with vaccine development and swine health consulting companies to speed product development, testing and manufacturing.

AgTechBiotechHealthtechChampaign, US

Aaron Gilbertie(CEO)Federico Zuckermann(Executive Officer, Director)

BoardRobert Easter(Director)Paul Olivo(Director)Gary Durack(Director)

Co-investorsMissouri Technology CorporationCultivation CapitalThe Yield LabBioGenerator VenturesIllinois VenturesThe Yield Lab Asia Pacific

FilterEasyfiltereasy.cominMay 2017SEC filingmedium confidence

FilterEasy is an online retailer that sells home air filters directly to consumers, with a focus on delivery and subscription-based replacement.

ConsumerDirect to ConsumerE-commerceRaleigh, US

Thaddeus W. Tarkington(Executive Officer, Director)Kevin J. Barry(Executive Officer, Director)in

BoardSteve Dauphin(Director)David E. Gardner(Director)inLister Delgado(Director)inTom Lotrecchiano(Director)

Board seatJohn Trbovich· per SEC Form D · $7M raise · filed Jul 2017

Co-investorsCofounders CapitalElevate Innovation PartnersModerne VenturesArsenal Growth EquityAzure Capital PartnersBonaventure Capital+4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

CoconaFrontline Technology SolutionsPlumSlice Labs

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.